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Confusion is a common presentation to acute medical services;
often in the setting ofmetabolic disturbance, such as alcoholic liver
disease. Seizure activity should always be considered as a
potentially reversible cause, and must be differentiated from
encephalopathy. This case also demonstrates that both focal and
generalised seizure activity can result from a metabolic cause
without a focal lesion.
2. Case report
A 45-year-old right handed female, with known alcoholic liver
disease, presented to the emergency department with post-ictal
confusion, after 10witnessed tonic–clonic seizures within an hour.
On arrival she was disorientated, and moving all four limbs in an
agitated manner. No further tonic–clonic seizures were observed,
and no spontaneousmovementswere noted during her emergency
department stay. Past history included a stable right ventriculo-
peritoneal shunt following removal of a benign brainstem tumour
20 years previously. Admission bloods were consistent with
decompensated liver disease (ALT 41, ALP 346, Bilirubin 112,
Platelets 114, Albumin 29, Prothombin time 20 s, INR 1.7) with
normal urea, electrolytes and blood glucose. Arterial blood gas
analysis revealed a lactic acidosis, which resolved over a period of
12 h. Lumbar puncture, undertaken after fresh frozen plasma, was* Corresponding author. Tel.: +44 7588457199.
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change. No further generalised seizures were witnessed during her
admission.
During the second week of admission she developed continu-
ous, irregular right-sided facial and upper limb twitching,
associated with right arm weakness and an expressive dysphasia.
She had no alcohol during her stay, and there were no reports of
pre-admission acute alcohol consumption to suggest alcohol
withdrawal seizures. There were no acute lesions on CT head,
and the scan appearances were unchanged from previous scans
over the last 3 years. Neurosurgical review conﬁrmed that the
previous surgery and the (MRI incompatible) right-sided shunt did
not provide an explanation for the patient’s deterioration.
Electroencephalography (EEG) on day 8 (Fig. 1), demonstrated
1 Hz periodic epileptic spike and wave discharges spreading
through the left hemisphere from the left fronto-central region,
reported as focal status, with mild slowing of the posterior
dominant rhythm of 7 Hz in the right hemisphere; reported as
compatible with amild encephalopathy. Her serum ammonia level
was mildly elevated at 85 ng/dl.
A diagnosis of continuous focal epilepsy (epilepsia partialis
continua, EPC) was made and levetiracetam was commenced
(250 mg bd) and subsequently titrated to 1 g bd. The facial and
upper limb twitching resolved within 24 h. The right arm
weakness and expressive dysphasia resolved. Her liver function
also improved, but did not normalise, in keeping with chronic liver
disease. At discharge bloods included: ALT 93, ALP 149, Bilirubin
23, platelets 149, albumin 34, PT 15 s, INR 1.3. A second EEG (Fig. 2)
on day 12 showed cessation of the epileptiform discharges, leaving
irregular slow waves in the left hemisphere. The posterior
dominant rhythm in the right hemisphere had increased to a
normal 8 Hz (compatible with resolved hepatic encephalopathy).
3. Discussion
Confusion is commonly associated with both acute and
chronic alcohol use. Hepatic encephalopathy is a serious
complication of alcoholic liver disease, with a number of
potential causes, and a poor prognosis.1 Differentiating seizure
activity from metabolic encephalopathy in alcoholic patients
with altered mentation is challenging from both clinical and
neurophysiological perspectives.vier Ltd. All rights reserved.
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Fig. 1. Initial EEG (day 8) – bipolar longitudinal montage: 1 Hz periodic fronto-central ‘spike and wave’ epileptiform discharges which project posteriorly through the left
hemisphere. The right hemisphere, by contrast, shows a 7 Hz posterior dominant rhythm which is consistent with a mild background encephalopathy.
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Fig. 2. Second EEG (day 12) – bipolar longitudinal montage: the left sided epileptiform discharges have now disappeared but the background remains very slow. The right
hemisphere, by contrast, now shows an 8 Hz posterior dominant rhythm.
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aetiology of confusion, and while these may have alternated
between seizures and hepatic encephalopathy prior to and during
the admission in our patient, it was the conﬁrmation of EPC on the
EEG that resulted in effective treatment. Reports of epileptic
seizures in patients with hepatic encephalopathy or severe liver
disease are rare.2,3 A case series over ten years found only 18 cases
(15%) of patient with hepatic encephalopathy had epileptiform
activity, 2/3 of those had clinical seizures (focal in 4 patients and
generalized in 8). As in our patient, neuroimaging failed to provide
a focal aetiology for the generation of epileptiform discharges in
most patients, including those with focal EEG abnormalities.
EPC is a focal motor status epilepticus without clinical or
electrical spread; lasting from 1 h up to weeks or even years.4,5Previous reports suggest EPCmost commonly affects the arm alone
(50%), but may also involve the leg (28%); or, as with our patient,
the face and arm (11%).4
An early study suggested that EPC may result from sub-cortical
pathology,6 but most evidence points to cortical dysfunction being
primarily responsible for the clinical manifestations of EPC.4 As a
result there is a drive to identify electrophysiological evidence of
focal epileptiform activity when making the diagnosis. The gold
standard is concomitant EMG and EEG, where back averaging
reveals a localised EEG spike that is temporally related to a muscle
jerk; or, when nerve stimulation produces a temporally related
stimulus evoked potential on EEG.4 Although such a temporal
relationship was not demonstrated on the electrophysiological
study of this patient, the focal nature of the epileptiform activity
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central dysfunction leading to right sided facial and upper limb
jerks with speech disturbance), is indicative of a focal epileptic
process such as EPC. Many patients with EPC are too unwell to
undergo back-averaging, and we rely on standard EEG conﬁrma-
tion of the clinical diagnosis.
It is possible that in our patient the two types of seizure activity
had separate pathologies. However, both generalised status
epilepticus,3 and EPC,2 have been described with hepatic
encephalopathy; and there is a previous report of patients with
both.2 Although focal structural causes are the most common
reported reason for EPC, generalised metabolic disturbances must
also be considered as a cause. In addition to liver disease, non
ketotic hyperosmolar hyperglycaemia with hyponatraemia,7,8
diabetic ketoacidosis9 and hypocalcaemia10 have all been reported
to cause EPC.
In general the prognosis of seizure activity in the setting of
hepatic encephalopathy is poor.2 In contrast, our patient
responded rapidly to oral anti-epileptic drugs. EPC can be difﬁcult
to treat,4,11 and there are no randomised controlled treatment
trials. Intravenous levetiracetam has been reported to lead to
resolution of EPC in a severely treatment resistant case.12
This case demonstrates that localised seizure activity, such as
EPC, can be due to a generalised metabolic disturbance and is not
always due to focal brain pathology. Our patient showed both
generalised and focal status epilepticus (manifesting as EPC) in the
setting of hepatic failure. Although encephalopathy is generally
neuro-depressant, it is important to consider seizure activity in
patients with metabolic disturbances as a potentially reversible
factor, and arrange for neurophysiological investigation in a timely
manner.
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